SB227

Ohio SB227 limits the cost sharing for prescription insulin drugs to $35 per thirty-day supply.

Ohio SB227 amends the state's Revised Code to cap the cost sharing for prescription insulin drugs at $35 per thirty-day supply. This applies to all health plan issuers providing coverage for these drugs under health benefit plans amended, issued, or renewed after the bill's effective date. The cost sharing is charged on a per-prescription-fill basis, regardless of the amount or type of insulin needed.